NORTHAMPTON, MA / ACCESSWIRE / June 14, 2023 / GRI: A new version of the Disability in Sustainability Reporting guide has been launched by Disability Hub Europe (DHUB), which takes account of recent ...

Company reported $8.2 million in cash and cash equivalents at December 31, 2025 and raised additional $6.5 million in gross proceeds in January 2026 Balance sheet strengthened to fund operations into ...

Trial shows GRI-0621 improved lung function with signs of fibrosis resolution GRI Bio has announced positive topline results from its phase 2a clinical trial evaluating GRI-0621 in idiopathic ...

The Sustainability Accounting Standards Board and the Global Reporting Initiative announced a collaborative work plan Monday to provide more clarity on how their two sets of standards can be used ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function LA JOLLA, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) ...

(RTTNews) - GRI Bio Inc. (GRI), a clinical-stage biopharmaceutical company, announced that the board has approved a 1-for-28 reverse stock split of the common stock to regain Nasdaq compliance for the ...

Global Reporting Initiative CEO Eelco van der Enden plans to step down at the end of the year when his three-year contract concludes on Dec. 31. Processing Content He was appointed CEO in January 2022 ...

The Global Reporting Initiative (GRI) has received approval by the Global Sustainability Standards Board (GSSB) for the project, which will see textiles and apparel become the latest addition to GRI’s ...

The Global Reporting Initiative (GRI) and the United Nations Global Compact (UNGC) have released “A Practical Guide” to enable companies to better measure and report on their impact on the Sustainable ...

The average one-year price target for GRI Bio (NasdaqCM:GRI) has been revised to $656.88 / share. This is an increase of 2,700.00% from the prior estimate of $23.46 dated January 11, 2026. The price ...